Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2019.09.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dose-Intensified Hypofractionated Stereotactic Body Radiation Therapy for Painful Spinal Metastases: Results of a Phase 2 Study

Cancer
Cancer ResearchOncology
2018English

Outcomes and Toxicity From a Prospective Study of Moderate Hypofractionated Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

(P044) Toxicity of Post-Operative Intensity Modulated Radiation Therapy in Patients With Cervical Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate Only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Improving Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: Results of a Randomized Phase 2 Trial

Cancer
Cancer ResearchOncology
2017English

Prostate Cancer and Hypofractionation: Reflections on Recent Randomised Phase III Clinical Trial Results

Translational Andrology and Urology
Reproductive MedicineUrology
2017English

Tri-Modality Therapy With I-125 Brachytherapy, External Beam Radiation Therapy, and Short- Or Long-Term Hormone Therapy for High-Risk Localized Prostate Cancer (TRIP): Study Protocol for a Phase III, Multicenter, Randomized, Controlled Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial

BJU International
Urology
2019English

Prospective Phase II Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy